H
Humacyte
Biotech & Life Sciences · Durham, United States · Founded 2004 Unicorn
Investors
8 investors on Humacyte's cap table
Sourced from Dealroom's funding history. Investor profile links are shown where available.
Global footprint
Where Humacyte has talent and traffic
team presence
across markets
Patent intelligence
$25M patent portfolio · 18 active families
Where Humacyte concentrates vs peers
Each axis is a top-10 topic across Humacyte and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Market sentiment
What the market is saying about Humacyte
An AI-synthesized read of the highest-engagement posts about Humacyte on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Humacyte on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.